This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
We examine withdrawal sustainability for Sp 500 versus Multi Asset retirement portfolios, focusing on income reliability, sequence of returns, and durability over time.
21,436 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Wall Street predicts these three AI stocks could double within four years as demand for AI infrastructure and memory ...
Nvidia dominates AI GPUs, but Broadcom could offer a different path into AI growth. This article lays out three concr...
In a crowded AI market, a stock nobody watching that quietly compounds growth could deliver outsized returns. This gu...
As AI models scale, the memory layer becomes the bottleneck that can shape profits. This piece explains why sandisk (...
JPMorgan raised its price target on Dell Technologies to 280 amid easing memory headwinds and a robust AI server back...
Hesai's early 2026 earnings signal a turning point for LiDAR tech adoption. This guide breaks down the Q1 results, wh...
A traditional publishing house rethinks growth with a bold AI push. A key investor just added $7 million to their sta...
A bold alliance between Allseas and a mining innovator aims to commercialize deep-sea nodule recovery. This strategic...
Synopsys posted solid quarterly results but faces Design IP headwinds. The path to a 2027 price target hinges on marg...
The AI build-out isn’t slowing Nvidia, with hyperscalers accelerating capex and expanding the AI stack. Investors are...
An AI-chip IPO like Cerebras can spark excitement and risk in one breath. cerebras opened $350 nearly, blasting past ...